Biportal endoscopic versus microscopic discectomy for lumbar herniated disc: a randomized controlled trial

医学 Oswestry残疾指数 随机对照试验 可视模拟标度 神经根痛 物理疗法 腰椎 外科 不利影响 生活质量(医疗保健) 腰痛 背痛 置信区间 内科学 替代医学 护理部 病理
作者
Sang‐Min Park,Ho-Jin Lee,Hyun‐Jin Park,Jun-Young Choi,Ohsang Kwon,Sanghoon Lee,Ho‐Joong Kim,Jin S. Yeom
出处
期刊:The Spine Journal [Elsevier BV]
卷期号:23 (1): 18-26 被引量:48
标识
DOI:10.1016/j.spinee.2022.09.003
摘要

Biportal endoscopic discectomy has been frequently performed in recent years and has shown acceptable clinical outcomes. However, evidence regarding its efficacy and safety remains limited.This study aimed to compare the clinical efficacy and safety of biportal endoscopic with that of open microscopic discectomy in patients with single-level herniated lumbar discs.Prospective, randomized, multicenter, open-label, assessor-blind, non-inferiority controlled trial.Sixty-four participants suffering from low back and leg pain with a single-level herniated lumbar disc and required discectomy.Outcomes were assessed with the use of patient-reported outcome measures (PROMs), visual analog scale (VAS) pain score for surgical site, low back and lower extremity, Oswestry Disability Index (ODI) for lumbar disabilities, European Quality of Life-5 Dimensions value for quality of life, and painDETECT for neuropathic pain. Surgery-related outcomes such as hospital stay, operation time, and opioid usage were collected. Adverse events occurring during the follow-up period were also noted.All participants were randomly assigned in a 1:1 ratio to undergo biportal endoscopic (biportal group) or microscopic discectomy (microscopy group). The primary outcome was the difference in ODI scores at 12-months post surgically based on a modified intention-to-treat strategy, with a non-inferiority margin of 12.8 points. The secondary outcomes included PROMs, surgery-related outcomes, and adverse events.The ODI score at the 12-month follow-up was 11.97 in the microscopy group and 13.89 in the biportal group (mean difference, 1.92; 95% confidence interval [CI], -3.50 to 7.34), showing the non-inferiority of biportal group. The results for the secondary outcomes were similar to those for the primary outcome. Creatinine phosphokinase ratios were low in the biportal group. Early surgical site pain was slightly lower in the biportal group (mean difference of VAS pain score at 48-hr, -0.98; 95% CI, -1.77 to -0.19). Adverse events including reoperation showed no significant difference between the groups.Biportal endoscopic discectomy was non-inferior to microscopic discectomy over a 12 month period. Biportal endoscopic discectomy is suggested to be a relatively safe and effective surgical technique with the slight advantage of reduced muscle damage. However, the clinical implications of surgical site pain should be carefully considered.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
Zhang应助淡定访琴采纳,获得10
2秒前
JC完成签到,获得积分10
2秒前
3秒前
3秒前
4秒前
liuuuuuu完成签到,获得积分10
4秒前
春和景明发布了新的文献求助10
5秒前
7秒前
地球发布了新的文献求助10
7秒前
9秒前
10秒前
shisan发布了新的文献求助10
10秒前
传奇3应助TYQ采纳,获得10
11秒前
尹雪儿完成签到 ,获得积分10
11秒前
lingling发布了新的文献求助20
12秒前
Jasper应助友好康乃馨采纳,获得10
13秒前
所所应助杪夏采纳,获得10
14秒前
思源应助超级梦桃采纳,获得10
14秒前
14秒前
majf完成签到 ,获得积分10
16秒前
17秒前
晶jing发布了新的文献求助10
17秒前
士多啤梨完成签到,获得积分10
18秒前
chen01hang应助zhangnan采纳,获得50
18秒前
李爱国应助jiang采纳,获得10
18秒前
20秒前
李健应助言希采纳,获得10
20秒前
小滑头完成签到,获得积分10
21秒前
21秒前
重要白桃完成签到,获得积分10
21秒前
木鸽子完成签到,获得积分10
21秒前
22秒前
shanLIU发布了新的文献求助10
23秒前
狂野的河马完成签到,获得积分0
24秒前
vvA11完成签到,获得积分10
24秒前
勤奋的松鼠完成签到,获得积分0
25秒前
cyan发布了新的文献求助10
25秒前
背后的鹭洋完成签到,获得积分0
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Organometallic Chemistry of the Transition Metals 800
Chemistry and Physics of Carbon Volume 18 800
The Organometallic Chemistry of the Transition Metals 800
The formation of Australian attitudes towards China, 1918-1941 640
Signals, Systems, and Signal Processing 610
全相对论原子结构与含时波包动力学的理论研究--清华大学 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6441943
求助须知:如何正确求助?哪些是违规求助? 8255854
关于积分的说明 17579385
捐赠科研通 5500641
什么是DOI,文献DOI怎么找? 2900348
邀请新用户注册赠送积分活动 1877230
关于科研通互助平台的介绍 1717112